Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia

NCT00766688 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

643

Enrollment

INDUSTRY

Sponsor class

Stopped AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy

Conditions

Hypercholesterolemia

Interventions

DRUG: AVE5530
DRUG: Placebo

Sponsor

Sanofi